Revisiting User Fees
January 1, 2005
Originally Published MX January/February 2005
INDUSTRY ASSOCIATIONS
In light of current failings, careful collaboration will be required to preserve the future of medical device user fees.
Mark Leahey
Mark Leahey is executive director of the Medical Device Manufacturers Association (Washington, DC), a trade association representing more than 200 medical technology companies. |
When Congress passed the Medical Device User Fee and Modernization Act of 2002 (MDUFMA, or the user-fee act), the goal of the user-fee program it created was to provide FDA with the resources it needed to review fully and in a timelier manner the safety and effectiveness of new medical devices. More than two years have passed since the inception of the program, time enough for many in the medical technology industry to evaluate seriously whether it is working as originally intended.
About the Author
You May Also Like